Clinical trialEPhase 1Terminated
Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic Cancer
Open Label Randomized Trial of Blood Transfusions in Cancer Patients Following a Pancreatectomy: A Feasibility Study
- Outcome
- Stopped earlyslow accrual (Enrollment)
- Phase
- EPhase 1
- Status
- Terminated
- Study type
- Interventional
- Start
- 10 August 2023
- Expected end
- 17 March 2025
- Enrollment
- 1 participants
- Sites
- 1
- Primary outcomes
- Rate of Protocol adherence
- Sponsor
- Other
- Results posted
- No
- Last update
- 10 June 2025
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
This clinical trial tests the the feasibility of testing a red blood cell transfusion threshold for improved quality of life for patients undergoing a pancreatectomy for pancreatic cancer. Pancreatectomy can be associated with significant blood loss. Blood loss can result in clinically important anemia causing fatigue. Pancreatic cancer itself can be associated with malnutrition and fatigue. Having a red blood cell transfusion threshold that results in a more liberal use of transfusions may improve quality of life for patients undergoing a pancreatectomy for pancreatic cancer.
Detailed description public domain (ClinicalTrials.gov)
PRIMARY OBJECTIVE: I. The primary objective for this pilot study is protocol adherence for the transfusion study we propose for pancreatectomy patients. SECONDARY OBJECTIVES: I. Determine the feasibility of collecting and processing of all data that will be collected in the full study. II. Specific emphasis will be given to findings from Patient Reported Outcomes Measurement Information System (PROMIS)-29 to determine its sensitivity to changes in health related quality of life (HRQOL) that occur in the perioperative period after pancreatectomy. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients undergo red blood cell transfusion if hemoglobin (Hgb) is less than 7 g/dL while on study. ARM II: Patients undergo red blood cell transfusion if Hgb is less than 9 g/dL while on study. Patients undergo computed tomography (CT) scan, x ray imaging, and blood sample collection throughout the study.